Down-regulation of DcR2 sensitizes androgen-dependent prostate cancer LNCaP cells to TRAIL-induced apoptosis.
Down-regulation of DcR2 sensitizes androgen-dependent prostate cancer LNCaP cells to TRAIL-induced apoptosis.
复制标题
DOI:
10.1186/1475-2867-11-42
复制
发表时间:
2011-12-02
影响因子:
5.8
通讯作者:
Grataroli R
中科院分区:
文献类型:
--
作者:
Vindrieux D;Réveiller M;Chantepie J;Yakoub S;Deschildre C;Ruffion A;Devonec M;Benahmed M;Grataroli R
Dysregulation of many apoptotic related genes and androgens are critical in the development, progression, and treatment of prostate cancer. The differential sensitivity of tumour cells to TRAIL-induced apoptosis can be mediated by the modulation of surface TRAIL receptor expression related to androgen concentration. Our previous results led to the hypothesis that downregulation of TRAIL-decoy receptor DcR2 expression following androgen deprivation would leave hormone sensitive normal prostate cells vulnerable to the cell death signal generated by TRAIL via its pro-apoptotic receptors. We tested this hypothesis under pathological conditions by exploring the regulation of TRAIL-induced apoptosis related to their death and decoy receptor expression, as also to hormonal concentrations in androgen-sensitive human prostate cancer, LNCaP, cells. In contrast to androgen-insensitive PC3 cells, decoy (DcR2) and death (DR5) receptor protein expression was correlated with hormone concentrations and TRAIL-induced apoptosis in LNCaP cells. Silencing of androgen-sensitive DcR2 protein expression by siRNA led to a significant increase in TRAIL-mediated apoptosis related to androgen concentration in LNCaP cells. The data support the hypothesis that hormone modulation of DcR2 expression regulates TRAIL-induced apoptosis in LNCaP cells, giving insight into cell death induction in apoptosis-resistant hormone-sensitive tumour cells from prostate cancer. TRAIL action and DcR2 expression modulation are potentially of clinical value in advanced tumour treatment.
登录
查看更多内容
影响因子:
3.6
作者:
Rokhlin, OW;Taghiyev, AF;Cohen, MB
通讯作者:
Cohen, MB
影响因子:
3.6
作者:
Grataroli, R;Vindrieux, D;Benahmed, M
通讯作者:
Benahmed, M
影响因子:
3.5
作者:
Pan, GH;Ni, J;Dixit, VM
通讯作者:
Dixit, VM
影响因子:
37.3
作者:
Belyanskaya, Larisa L.;Marti, Thomas M.;Hopkins-Donaldson, Sally;Kurtz, Stefanie;Felley-Bosco, Emanuela;Stahel, Rolf A.
通讯作者:
Stahel, Rolf A.
DOI:
10.1084/jem.186.7.1165
发表时间:
1997-10-06
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Degli-Esposti MA;Smolak PJ;Walczak H;Waugh J;Huang CP;DuBose RF;Goodwin RG;Smith CA
通讯作者:
Smith CA